The contribution of muscle to the generation of fibromyalgia symptomatology

Journal of Musculoskeletal Pain

Volumn 4, Issue 1-2, 1996, Pages 35-60

  Bennett, Robert M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROMYALGIA; FIBROSITIS; GLYCOGEN MUSCLE LEVEL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MUSCLE BIOPSY; MUSCLE BLOOD FLOW; MUSCLE METABOLISM; MUSCLE STRENGTH; PATHOGENESIS; REVIEW; SARCOLEMMA; STRESS STRAIN RELATIONSHIP; TRAPEZIUS MUSCLE;

EID: 0029916601     PISSN: 10582452     EISSN: None     Source Type: Journal    
DOI: 10.1300/J094v04n01_05     Document Type: Review

References (96)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arm Rheum 33:160-172, 1990.
2. Gowers WR: Lumbago: Its lessons and analogues. BMJ 1:117-121, 1904.
3. Stockman R: The causes, pathology, and treatment of chronic rheumatism. Edinburgh Medical J 15:107-116, 1904.
4. Brendstrup P, Jespersen K, Asboe-Hansen G: Morphological and chemical connective tissue changes in fibrositis muscles. Ann Rheum Dis 16:438-440, 1957.
5. Awad EA: Interstitial myofibrositis: Hypothesis of the mechanism. Arch Phys Med 54:449-452, 1973.
6. Miehlke K, Schulze G, Eger W: Klinische und experimentelle untersuchungen zum fibrositissyndrom. Zeitschrift fur Rheumaforschung 19:310-330, 1960.
7. Fassbender HG: Pathology of Rheumatic Disease. New York, Springer Verlag, 1975.
8. Bengtsson A, Henriksson KG, Larsson J: Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arth Rheum 29:817-821, 1986.
9. Yunus MD, Kalyan-Raman UP, Masi AT, Aldag JC: Electromicroscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 16:97-101, 1989.
10. Lindman R, Hagberg M, Angqvist KA, Soderlund K, Hultman E, Thornell LE: Changes in muscle morphology in chronic trapezius myalgia. Scand J Work Environ Health 17:347-355, 1991.
11. Lindman R, Eriksson A, Thornell LE: Fiber type composition of the human female trapezius muscle: enzyme-histochemical characteristics. Am J Anatomy 190:385-392, 1991.
12. Mathur AK, Gatter RA: Abnormal 31P-NMR spectroscopy of painful muscles of patients with fibromyalgia (abs). Arth Rheum 31:S23, 1988.
13. Jacobsen S, Jensen KE, Thomsen C, Danneskiold-Samsoe B, Henriksen O: [Magnetic resonance spectroscopy in fibromyalgia. A study of phosphate-31 spectra from skeletal muscles during rest and after exercise]. Ugeskr Laeger 156: 6841-6844, 1994.
14. Jacobsen S, Jensen KE, Thomsen C, Danneskiold-Samsoe B, Henriksen O: 31P magnetic resonance spectroscopy of skeletal muscle in patients with fibromyalgia. J Rheumatol 19:1600-1603, 1992.
15. Roy SH: Combined use of surface electromyography and 31P-NMR spectroscopy for the study of muscle disorders. Phys Ther 73:892-901, 1993.
16. de Blëcourt AC, Wolf RF, van Rijswijk MH, Kamman RL, Knipping AA, Mooyaart EL: In vivo 31P magnetic resonance spectroscopy (MRS) of tender points in patients with primary fibromyalgia syndrome. Rheumatol Int 11:51-54, 1991.
17. Simms RW, Roy SH, Hrovat M, Anderson JJ, Skrinar G, LePoole SR, Zerbini CA, de Luca C, Jolesz F: Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism [see comments]. Arthritis Rheum 37:794-800, 1994.
18. Jubrias SA, Bennett RM, Klug GA: Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients [see comments]. Arthritis Rheum 37:801-807, 1994.
19. Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B: 31P-NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 37:165-169, 1987.
20. Satrustegui J, Berkowitz H, Boden B, Donlon E, McLaughlin A, Maris J, Warnell R, Chance B: An in vivo phosphorus nuclear magnetic resonance study of the variations with age in the phosphodiers content of human muscle. Mech Aging Develop 42:105-114, 1988.
21. Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafede RP, Porter J, Specht D: Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arth Rheum 32:454-460, 1989.
22. Sietsema KE, Cooper DM, Caro X, Leibling MR, Louie JS: Oxygen uptake during exercise in patients with primary fibromyalgia syndrome. J Rheumatol 20:860-865, 1993.
23. Mengshoel AM, Forre O, Komnaes HB: Muscle strength and aerobic capacity in primary fibromyalgia. Clin Exp Rheumatol 8:475-479, 1990.
24. Clark SR, Burckhardt CS, Campbell S, O'Reilly C, Bennett RM: Fitness characteristics and perceived exertion in women with fibromyalgia. J Musculoskeletal Pain 1(3/4):191-197, 1993.
25. Henriksson KG: Chronic muscular pain: aetiology and pathogenesis. Baillieres Clin Rheumatol 8:703-719, 1994.
26. Lindman R, Hagberg M, Bengtsson A, Henriksson KG, Thornell LE: Capillary structure and mitochondrial volume density in the trapezius muscle of chronic trapezius myalgia, fibromyalgia, and healthy subjects. J Musculoske Pain 3(3): 5-22, 1995.
27. Lund N, Bengtsson A, Thorborg P: Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15:165-173, 1986.
28. Klemp P, Nielsen HV, Korsgard J, et al. Blood flow in fibromyotic muscles. Scand J Rehab Med 14:81-86, 1982.
29. Jacobsen S, Danneskiold-Samsoe B: Isometric and isokinetic muscle strength in patients with fibrositis syndrome. New characteristics for a difficult definable category of patients. Scand J Rheumatol 16:61-65, 1987.
30. Elert JE, Rantapäa-Dahlqvist SB, Henriksson-Larsen K, Lorentzon R, Gerdle BU: Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia. Scand J Rheumatol 21:28-34, 1992.
31. Nordenskiöld UM, Grimby G: Grip force in patients with rheumatoid arthritis and fibromyalgia and in healthy subjects. A study with the Grippit instrument. Scand J Rheumatol 22:14-19, 1993.
32. Lindh MH, Johansson LG, Hedberg M, Grimby GL: Studies on maximal voluntary muscle contraction in patients with fibromyalgia. Arch Phys Med Rehabil 75:1217-1222, 1994.
33. Elert J, Dahlqvist SR, Almay B, Eismann M: Muscle endurance, muscle tension, and personality traits in patients with muscle or joint pain - a pilot study. J Rheumatol 20:1550-1556, 1995.
34. Jacobsen S, Danneskiold-Samsoe B: Dynamic muscular endurance in primary fibromyalgia compared with chronic myofascial pain syndrome. Arch Phys Med Rehabil 73:170-173, 1992.
35. Jensen LT, Jacobsen S, Horsley-Petersen K: Serum procollagen type III aminoterminal peptide in primary fibromyalgia (fibrositis syndrome) [letter]. Br J Rheumatol 27:496, 1988.
36. Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 35:1113-1116, 1992.
37. Backman E, Bengtsson A, Bengtsson M, Lennmarken C, Henriksson KG: Skeletal muscle function in primary fibromyalgia. Effect of regional sympathetic blockade with guanethidine. Acta Neurol Scand 77:187-191, 1988.
38. Jacobsen S, Wildschiodtz G, Danneskiold-Samsoe B: Isokinetic and isometric muscle strength combined with transcutaneous electrical muscle stimulation in primary fibromyalgia syndrome. J Rheumatol 18:1390-1393, 1991.
39. Zidar J, Backman E, Bengtsson A, Henriksson KG: Quantitative EMG and muscle tension in painful muscles in fibromyalgia. Pain 40:249-254, 1990.
40. Svebak S, Anjia R, Karstad SI: Task-induced electromyographic activation in fibromyalgia subjects and controls. Scand J Rheumatol 22:124-130, 1993.
41. Elert JE, Rantapäa-Dahlqvist SB, Henriksson-Larsen K, Gerdle B: Increased EMG activity during short pauses in patients with primary fibromyalgia. Scand J Rheumatol 18:321-323, 1989.
42. Edwards RHT: Hypotheses of peripheral and central mechanisms underlying occupational muscle pain and injury. Eur J Appl Physiol 57:275-281, 1988.
43. Edwards RH, Newham DJ, Jones DA, Chapman SJ: Role of mechanical damage in pathogenesis of proximal myopathy in man. Lancet 1:548-552, 1984.
44. Yunus MB, Berg BC, Masi AT: Multiphase skeletal scintigraphy in primary fibromyalgia syndrome: A blinded study. J Rheumatol 16:1466-1468, 1989.
45. Jaeger B, Skootsky SA: Double-blind, controlled study of different myofascial trigger point injection techniques. Pain 31:S292, 1987.
46. Travell JG, Simons DG: Myofascial pain and dysfunction: the trigger point manual. Baltimore, Williams & Wilkins, 1983.
47. Bengtsson A, Henriksson KG, Jorfeldt L, Kagedal B, Lennmarken C, Lindstrom F: Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scand J Rheumatol 15:340-347, 1986.
48. Bengtsson M, Bengtsson A, Jorfeldt L: Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain 39:171-180, 1989.
49. Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 54:241-289, 1993.
50. Brimijoin S, Lundberg JM, Brodin E, Hokfelt T, Nilsson G: Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig. Brain Res 191:443-457, 1980.
51. Arroyo JF, Cohen ML: Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 20:1925-1931, 1993.
52. Gibson SJ, Littlejohn GO, Gorman MM, Helme RD, Granges G: Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 58:185-193, 1994.
53. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, Stewart KE, Alarcon GS, Mountz JD: Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38:926-938, 1995.
54. Hoheisel U, Mense S: Response behavior of cat dorsal horn neurones receiving input from skeletal muscle and other deep somatic tissues. Journal of Physiology 426:265-280, 1990.
55. Dubner R: Hyperalgesia and expanded receptive fields. Pain 48:3-4, 1992.
56. Dickenson AH, Sullivan AF: NMDA receptors and central hyperalgesic states. Pain 46:344-345, 1991.
57. Coderre TJ, Katz J, Vaccarino AL, Melzack R: Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259-285, 1993.
58. Calverley RKS, Jones DK: Contributions of dendritic spines and perforated synapses to synaptic plasticity. Brain Research Reviews 15:215-249, 1990.
59. Mantyh PW, DeMaster E, Malhotra A, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE: Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 268: 1629-1632, 1995.
60. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F: Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37:1593-1601, 1994.
61. Arnetz BB, Fjellner B: Psychological predictors of neuroendocrine responses to mental stress. J Psychosom Res 30:297-305, 1986.
62. Hoheisel U, Mense S: Response behaviour of cat dorsal horn neurones receiving input from skeletal muscle and other deep somatic tissues. J Physiol (Lond) 426:265-280, 1990.
63. Hoheisel U, Mense S, Simons DG, Yu XM: Appearance of new receptive fields in rat dorsal horn neurons following noxious stimulation of skeletal muscle: a model for referral of muscle pain? Neurosci Lett 153:9-12, 1993.
64. Sastry BR: Substance P effects on spinal nociceptive neurones. Life Sci 24:2178, 1979.
65. Yu XM, Mense S: Response properties and descending control of rat dorsal horn neurons with deep receptive fields. Neuroscience 39:823-831, 1990.
66. Basbaum AI, Fields HL: Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309-338, 1984.
67. Yu XM, Hua M, Mense S: The effects of intracerebroventricular injection of naloxone, phentolamine and methysergide on the transmission of nociceptive signals in rat dorsal horn neurons with convergent cutaneous-deep input. Neuroscience 44:715-723, 1991.
68. Russell IJ: Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 15:149-168, 1989.
69. Liu H, Brown JL, Jasmin L, Maggio JE, Vigna SR, Mantyh PW, Basbaum AI: Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc Natl Acad Sci USA 91:1009-1013, 1994.
70. Wall PD, Woolf CJ: Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol 356:443-458, 1984.
71. Armstrong RB, Warren GL, Warren JA: Mechanisms of exercise-induced muscle fibre injury. Sports Med 12:184-207, 1991.
72. Jones DA, Newham DJ, Torgan C: Mechanical influences on long-lasting human muscle fatigue and delayed-onset pain. J Physiol (Lond) 412:415-427, 1989.
73. Howell JN, Chleboun G, Conatser R: Muscle stiffness, strength loss, swelling and soreness following exercise-induced injury in humans. J Physiol 464: 183-196, 1993.
74. Friden J: Muscle soreness after exercise: implications of morphological changes. Int J Sports Med 5:57-66, 1984.
75. Friden J, Sjostrom M, Ekblom B: A morphological study of delayed muscle soreness. Experientia 37:506-507, 1981.
76. Stauber WT, Clarkson PM, Fritz VK, Evans WJ: Extracellular matrix disruption and pain after eccentric muscle action. Am Physiol Soc 161-7567: 868-874, 1990.
77. Armstrong RB: Mechanisms of exercise-induced delayed onset muscular soreness: a brief review. Med Sci Sports Exerc 27:1101-1106, 1984.
78. Jackson MJ, Jones DA, Edwards RHT: Experimental skeletal muscle damage: the nature of the calcium-activated degenerative process. Eur J Clin Invest 14:369-374, 1984.
79. Belcastro AN: Skeletal muscle calcium-activated neutral protease (calpain) with exercise. J Appl Physiol 74:1381-1386, 1993.
80. Newham DJ, Jones DA, Edwards RH: Large delayed plasma creatine kinase changes after stepping exercise. Muscle Nerve 6:380-385, 1983.
81. Newham DJ, Jones DA, Tolfree SE, Edwards RH: Skeletal muscle damage: a study of isotope uptake, enzyme efflux and pain after stepping. Eur J Appl Physiol 55:106-112, 1986.
82. Newham DJ, Jones DA, Edwards RH: Plasma creatine kinase changes after eccentric and concentric contractions. Muscle Nerve 9:59-63, 1986.
83. Newham DJ, Jones DA, Clarkson PM: Repeated high-force eccentric exercise: effects on muscle pain and damage. J Appl Physiol 63:1381-1386, 1987.
84. Ono N, Samson WK, McDonald JK, Lumpkin MD, Bedran de Castro JC, McCann SM: Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones. Proc Natl Acad Sci USA 82:7787-7790, 1985.
85. Merskey H: Physical and psychological considerations in the classification of fibromyalgia. J Rheumatol 16 Suppl. 19:72-79, 1989.
86. Yunus MB, Ahles TA, Aldag JC, Masi AT: Relationship of clinical features with psychological status in primary fibromyalgia. Arth Rheum 34:15-21, 1991.
87. Boissevain MD, McCain GA: Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects. Pain 45:239-248, 1991.
88. Gamsa A: The role of psychological factors in chronic pain. II. a critical appraisal. Pain 57:17-29, 1994.
89. Henriksson C, Gundmark I, Bengtsson A, Ek AC: Living with fibromyalgia. Consequences for everyday life. Clin J Pain 8:138-144, 1992.
90. Henriksson CM: Living with continuous muscular pain-patient perspectives. Part I: Encounters and consequences. Scand J Caring Sci 9:67-76, 1995.
91. Henriksson CM: Long term effects of fibromyalgia on everyday life. A study of 56 patients. Scand J Rheumatol 23:36-41, 1994.
92. Yunus MB: Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres Clin Rheumatol 8:811-837, 1994.
93. Branco J, Atalaia A, Paiva T: Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 21:1113-1117, 1994.
94. Moldofsky H: Chronobiological influences on fibromyalgia syndrome: theoretical and therapeutic implications. Baillieres Clin Rheumatol 8:801-810, 1994.
95. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL: Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37: 1583-1592, 1994.
96. Moldofsky H, Scarisbrick P: Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 38:35-44, 1976.